Abstract：
Transcatheter therapies for the treatment of structural heart diseases (SHD) have expanded dramatically over the last years, thanks to the developments and improvements of devices and imaging techniques, along with the increasing expertise of operators. Imaging, in particular echocardiography, is pivotal during patient selection, procedural monitoring, and follow-up. The imaging assessment of patients undergoing transcatheter interventions places demands on imagers that differ from those of the routine evaluation of patients with SHD, and there is a need for specific expertise for those working in the cath lab. In the context of the current rapid developments and growing use of SHD therapies, this document intends to update the previous consensus document and address new advancements in interventional imaging for access routes and treatment of patients with aortic stenosis and regurgitation, and mitral stenosis and regurgitation.
摘要：
在过去的几年中，用于治疗结构性心脏病（SHD）的经导管疗法已急剧发展。由于设备和成像技术的发展和改进，随着运营商专业知识的增加。成像,特别是超声心动图,在患者选择过程中至关重要，程序监控，和后续行动。接受导管介入治疗的患者的影像学评估对成像器的要求与SHD患者的常规评估不同。对于那些在cath实验室工作的人来说，需要特定的专业知识。在当前快速发展和SHD疗法日益广泛使用的背景下，本文件旨在更新先前的共识文件，并探讨介入成像在主动脉瓣狭窄和反流患者的入路和治疗方面的新进展。二尖瓣狭窄和反流.
